SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037555
Filing Date
2022-11-14
Accepted
2022-11-14 13:00:43
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-10q_20220930.htm   iXBRL 10-Q 1971034
2 EX-31.1 cbio-ex311_9.htm EX-31.1 14107
3 EX-31.2 cbio-ex312_6.htm EX-31.2 14113
4 EX-32.1 cbio-ex321_8.htm EX-32.1 9725
5 EX-32.2 cbio-ex322_7.htm EX-32.2 9731
6 GRAPHIC ga5wdcyx3uht000001.jpg GRAPHIC 38951
  Complete submission text file 0001564590-22-037555.txt   6739207

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220930.xsd EX-101.SCH 48783
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbio-20220930_cal.xml EX-101.CAL 39740
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbio-20220930_def.xml EX-101.DEF 115778
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220930_lab.xml EX-101.LAB 346065
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220930_pre.xml EX-101.PRE 247601
59 EXTRACTED XBRL INSTANCE DOCUMENT cbio-10q_20220930_htm.xml XML 1185554
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 221383047
SIC: 2834 Pharmaceutical Preparations